Pharsight

BAYER PHARMA patents facing oppositions

Top patents of BAYER PHARMA facing oppositions at the European Patent Office (EPO).

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP3325013B2 19 Jul, 2023 Stimulators / activators of soluble guanylat cyclase in combination with a nep-inhibitor and an angiotensin aii-antagonist and the use thereof Jul, 2036 1
EP3611169B1 21 Jul, 2021 New gadolinium chelate compounds for use in magnetic resonance imaging May, 2036 1
EP3303307B1 04 Sep, 2019 New gadolinium chelate compounds for use in magnetic resonance imaging NA 1
EP2532676B1 22 Mar, 2017 Protease-regulated antibody NA 1